The canonical SMILES is C[N+]1=CC=CC2=C(C=CC=C21)N, the InChIKey is ZMJBCEIHNOWCMC-UHFFFAOYSA-O, and the monoisotopic mass of the cation is 159.0922 Da, providing convenient reference points for LC-MS confirmation and library matching
From available case reports, compounding pharmacy data, and practitioner experience, the following have been observed: BPC-157 Reported Side Effects Nausea and gastrointestinal discomfort (especially with oral administration) Dizziness or light-headedness Flushing or warmth at injection sites Headache Fatigue or somnolence in some users TB-500 Reported Side Effects Injection site reactions (redness, mild pain, swelling) Transient fatigue or lethargy following administration Headache Possible flu-like symptoms in a minority of users Critical Risk Note: Because neither peptide has undergone full clinical trial evaluation in humans, the complete adverse event profile is unknown
Lets build a smarter path to your weight loss goalsone that supports your energy, metabolism, and long-term results
Anti-Inflammatory Action: Sciatica is, at its core, an inflammatory problem
By attenuating NNMT activity, 5Amino1MQ has been observed in preclinical settings to elevate NAD+ availability, enhance metabolic flux, and upregulate downstream signaling programs associated with cellular stress responses and energy expenditure (e.g., SIRT1)
